http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d90aa796fc95b16da8e91078fce35888

Outgoing Links

Predicate Object
family-name Vangrevelinghe
name Eric Vangrevelinghe
given-name Eric
organization-name Oncology Research, Novartis Institutes for BioMedical Research, 4056 Basel, Switzerland
Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland
Novartis Biomedical Research, CH-4002 Basel, Switzerland
Institut de Chimie Organique et Analytique, associé au CNRS, Université d’Orléans, BP-6759, 45067 Orléans Cedex 2, France, ADIR et Cie, 1 rue Carle Hébert, 92415 Courbevoie, France, and Laboratoire de Chimie Thérapeutique, Faculté de Pharmacie de Toulouse, Université Paul Sabatier, 35 chemin des Maraîchers, 31400 Toulouse, France
Oncology Research, NOVARTIS Pharma AG, 4002 Basle, Switzerland
Oncology Research, Novartis Pharma AG, 4002 Basle, Switzerland, and Nervous System Research, Novartis Pharma AG, CH-4002 Basle, Switzerland, and Process R&D, Novartis Pharma AG, CH-4002 Basle, Switzerland
Authors' Affiliations: 1Disease Area Oncology, 2Developmental and Molecular Pathways, 3Global Discovery Chemistry, 4Center for Proteomic Chemistry, Novartis Institutes for BioMedical Research, Basel, Switzerland; 5Human Oncology and Pathogenesis Program and Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center; and 6Gerstner Sloan-Kettering Graduate School of Biomedical Sciences, New York
Novartis Institutes for BioMedical Research, Basel CH4002, Switzerland
Global Discovery Chemistry, Novartis Institutes for Biomedical Research, 4002 Basel, Switzerland
Novartis Institutes for BioMedical Research, Forum 1, Novartis Campus, CH-4002 Basel, Switzerland
Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland
Novartis Institute for Biomedical Research, CH-4057 Basel, Switzerland 6
Authors' Affiliations: 1Disease Area Oncology, 2Global Discovery Chemistry, 3Center for Proteomic Chemistry, 4Metabolism and Pharmacokinetics, and 5Preclinical Safety Clinical Pathology, Novartis Institutes for BioMedical Research, Basel, Switzerland

Incoming Links

Predicate Subject
creator http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1091883
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10806283
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35727662
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/4616706
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25522106
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36697819
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28261559
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9529098
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5685384
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1837163
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9146682
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7434876
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24712935
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9949687
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36140870
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/208252917
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26315962
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22135736
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/427109
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1811421
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24945375
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3146257
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6562543
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19521091
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21513118
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34052202
http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27073324

Total number of triples: 43.